R A Califf

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We determined the efficacy of abciximab, a platelet glycoprotein IIb/IIIa receptor antagonist, combined with low-dose weight-adjusted heparin in reducing ischemic complications in patients undergoing(More)
  • 1